Clincosm LogoSign in Get a demo

Major Depressive Disorder

Showing NaN - NaN of 75
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

MDD Trial in United States (Antidepressant + , Antidepressant + cariprazine (0.1-0.3 mg/day), Antidepressant + cariprazine (1-2

Completed
Has Results
  • Major Depressive Disorder
  • Antidepressant + placebo
  • +2 more
  • Phoenix, Arizona
  • +40 more
Feb 12, 2019

MDD Trial in Mexico, United States (desvenlafaxine succinate sustained release, fluoxetine, )

Completed
Has Results
  • Major Depressive Disorder
  • desvenlafaxine succinate sustained release
  • +2 more
  • Dothan, Alabama
  • +42 more
Jan 2, 2019

MDD Trial in Worldwide (ALKS 5461)

Completed
Has Results
  • Major Depressive Disorder
  • ALKS 5461
  • Birmingham, Alabama
  • +157 more
Nov 21, 2018

MDD Trial in United States (Switching: Bupropion-SR, Augmenting: Antidepressant + Bupropion-SR, Augmenting: Antidepressant +

Completed
Has Results
  • Major Depressive Disorder
  • Switching: Bupropion-SR
  • +2 more
  • Tuscaloosa, Alabama
  • +34 more
Apr 25, 2018

MDD Trial in Worldwide (Placebo, Cariprazine)

Completed
Has Results
  • Major Depressive Disorder
  • Garden Grove, California
  • +71 more
Mar 29, 2018

MDD Trial in Worldwide (LY2216684, Placebo, SSRI)

Completed
Has Results
  • Major Depressive Disorder
  • Irvine, California
  • +62 more
Mar 17, 2018

MDD Trial in United States (vilazodone)

Completed
Has Results
  • Major Depressive Disorder
  • Garden Grove, California
  • +37 more
Aug 22, 2017

MDD Trial in Chile, United States (DVS SR)

Completed
Has Results
  • Major Depressive Disorder
  • DVS SR
  • Birmingham, Alabama
  • +35 more
Jun 28, 2017

MDD Trial in Chile, Mexico, United States (Desvenlafaxine Succinate Sustained-Release, Placebo)

Completed
Has Results
  • Major Depressive Disorder
  • Desvenlafaxine Succinate Sustained-Release
  • Placebo
  • Birmingham, Alabama
  • +41 more
Jan 30, 2017

MDD Trial in United States (80 Milligrams NSI-189, Placebo, 40 Milligrams NSI-189)

Unknown status
  • Major Depressive Disorder
  • 80 Milligrams NSI-189
  • +2 more
  • Garden Grove, California
  • +12 more
Feb 23, 2017

MDD Trial in Mexico, United States (DVS SR)

Completed
Has Results
  • Major Depressive Disorder
  • DVS SR
  • Dothan, Alabama
  • +34 more
Dec 16, 2016

MDD Trial in Worldwide (Placebo, RO4917523 0.5 mg, RO4917523 1.5 mg)

Completed
  • Major Depressive Disorder
  • Placebo
  • +2 more
  • Little Rock, Arkansas
  • +75 more
Nov 1, 2016

NSI-189, With Out-Patients With Major Depressive Disorder

Unknown status
  • Major Depressive Disorder
  • Garden Grove, California
  • +11 more
Sep 20, 2016

MDD Trial in United States (NRX-1074 1 mg, Placebo, NRX-1074 5 mg)

Completed
  • Major Depressive Disorder
  • NRX-1074 1 mg
  • +3 more
  • Oakland, California
  • +11 more
Feb 18, 2016

MDD, Irritability Trial in United States (Brexpiprazole)

Completed
Has Results
  • Major Depressive Disorder
  • Irritability
  • Tucson, Arizona
  • +14 more
Feb 16, 2016

MDD Trial in United States (OPC-34712, Placebo, ADT)

Completed
Has Results
  • Major Depressive Disorder
  • Arcadia, California
  • +49 more
Feb 2, 2016

MDD Trial in United States (EB-1010 25mg BID, SSRI Active, EB-1010 50mg BID)

Completed
  • Major Depressive Disorder
  • EB-1010 25mg BID
  • +3 more
  • Arcadia, California
  • +42 more
Nov 5, 2015

MDD Trial in United States (OPC-34712, Placebo, ADT)

Completed
Has Results
  • Major Depressive Disorder
  • Birmingham, Alabama
  • +42 more
Sep 30, 2015

MDD Trial in United States (tasimelteon, )

Completed
Has Results
  • Major Depressive Disorder
  • Garden Grove, California
  • +39 more
Jun 1, 2015

MDD Trial in Worldwide (Placebo, Vilazodone)

Completed
  • Major Depressive Disorder
  • Beverly Hills, California
  • +74 more
May 15, 2015

MDD Trial in United States (Vilazodone, Placebo to citalopram, Placebo to vilazodone)

Completed
Has Results
  • Major Depressive Disorder
  • Birmingham, Alabama
  • +53 more
Aug 6, 2014

MDD Trial in United States (Levomilnacipran ER, Paroxetine, Sertraline, Citalopram or Fluoxetine., Placebo)

Completed
Has Results
  • Major Depressive Disorder
  • Levomilnacipran ER
  • +2 more
  • Birmingham, Alabama
  • +19 more
Aug 5, 2014

MDD Trial in United States (Placebo, Escitalopram, JNJ-18038683)

Completed
  • Major Depressive Disorder
  • Placebo
  • +2 more
  • Little Rock, Arkansas
  • +25 more
Aug 1, 2014

MDD, Depression Trial in India, Puerto Rico, United States (TC-5214, Placebo)

Completed
Has Results
  • Major Depressive Disorder
  • Depression
  • Birmingham, Alabama
  • +98 more
Mar 14, 2014

MDD Trial in United States (Dose-matched , Vilazodone)

Completed
Has Results
  • Major Depressive Disorder
  • Beverly Hills, California
  • +13 more
Feb 21, 2014